Peritonitis in peritoneal dialysis patients in Japan: A 2013 retrospective questionnaire survey of Japanese Society for Peritoneal Dialysis member institutions

被引:0
|
作者
Higuchi C. [1 ]
Ito M. [2 ]
Masakane I. [2 ]
Sakura H. [1 ]
机构
[1] Department of Medicine, Tokyo Women's Medical University Medical Center East, 2-1-10 Nishiogu Arakawa-ku, Tokyo
[2] Yabuki Hospital, 4-5-5 Shimakita, Yamagata City, Yamagata
关键词
Antibiotic administration methods; Catheter exit-site infection; Effluent culture technique; PD peritonitis incidence; Previous peritonitis episodes;
D O I
10.1186/s41100-016-0014-6
中图分类号
学科分类号
摘要
Background: Peritonitis is the main cause of withdrawal from peritoneal dialysis (PD) therapy in Japan. The precise extent of PD-associated peritonitis in Japan has not been investigated since 2005; we aimed to clarify the recent incidence and prognosis of PD peritonitis. Methods: The 248 institutional members of the Japanese Society for Peritoneal Dialysis were surveyed by questionnaire regarding peritonitis episodes during January 1 to December 31, 2013. Results: Replies from 114 members were received regarding 3042 PD patients, including 516 peritonitis patients, covering a total observation period of 31,686 patient months. The incidence of peritonitis in this study was 0.195 episodes per year. Detailed data on 544 peritonitis episodes in 466 patients was obtained. The causes, in ranked order, were unknown reason, contamination at peritoneal fluid exchange, and extension of intra-abdominal cavity infection. Effluent culture methods included using a blood culture bottle (50.9 %), large-volume culture (culturing sediment after centrifuging effluent) (31.7 %), and direct culture of effluent using a culture dish (12.7 %). The rank order of microbes identified in peritoneal effluent cultures was culture-negative, Streptococcus sp. and Staphylococcus aureus. Empiric therapy with two kinds of antibiotics was administered to 406 cases (75.2 %), most commonly cefazolin + ceftazidime. Antibiotic administration methods included intraperitoneal (51.4 %), intravenous (46.4 %), and oral (2.2 %). After a peritonitis episode, 461 patients (84.7 %) continued PD therapy, 80 (14.7 %) withdrew from PD treatment, and 6 (1.1 %) died. Prognosis among patients grouped by antibiotic administration method was statistically significantly different; in the oral administration group, the rates of mortality and catheter replacement were higher. Logistic regression analysis showed that catheter exit-site infection and frequency of past peritonitis episodes were independent factors associated with PD treatment withdrawal. Conclusions: Although the overall incidence of PD peritonitis in Japan was relatively low, several areas for future improvement were identified: Unknown reason and culture-negative were the most frequently cited causes of peritonitis; 1.1 % of patients died, and 13.6 % discontinued PD therapy. Improvements in effluent culture techniques, antibiotic administration methods, etiology determination, and patient education could help. A more effective protocol must be established to further improve the treatment of PD peritonitis in Japan. © 2016 The Author(s).
引用
收藏
相关论文
共 50 条
  • [21] Mycobacterial peritonitis in pediatric peritoneal dialysis patients
    Elizabeth Ferrara
    Jacques Lemire
    Paul C. Grimm
    Vivian M. Reznik
    Stanley A. Mendoza
    John A. Leake
    Nadine M. Benador
    Pediatric Nephrology, 2004, 19 : 114 - 117
  • [22] Prototheca Wickerhami peritonitis in patients on peritoneal dialysis
    Melon, C. Perez
    Camba, M.
    Tinajas, A.
    Otero, A.
    Iglesias, A.
    Armada, E.
    Esteban, J.
    NEFROLOGIA, 2007, 27 (01): : 81 - 82
  • [23] PERITONITIS IN PERITONEAL DIALYSIS PATIENTS REQUIRING HOSPITALIZATION
    Falk, I. N.
    Colombo, R.
    Baer, S.
    Kheda, M.
    Iwuagwu, N.
    Huber, L.
    Nahman, N. S.
    Kintziger, K.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2014, 62 (02) : 554 - 554
  • [24] Peritonitis in pediatric patients receiving peritoneal dialysis
    Jellouli, Mane
    Ferjani, Meriem
    Abidi, Kamel
    Hammi, Yosra
    Boutiba, Ilhem
    Naija, Ouns
    Zarrouk, Chokri
    Ben Abdallah, Taieb
    Gargah, Tahar
    NEPHROLOGIE & THERAPEUTIQUE, 2015, 11 (07): : 558 - 563
  • [25] Peritoneal Dialysis Registry With 2013 Survey Report
    Masakane, Ikuto
    Hasegawa, Takeshi
    Ogata, Satoshi
    Kimata, Naoki
    Nakai, Shigeru
    Hanafusa, Norio
    Hamano, Takayuki
    Wakai, Kenji
    Wada, Atsushi
    Nitta, Kosaku
    THERAPEUTIC APHERESIS AND DIALYSIS, 2016, 20 (06) : 557 - 568
  • [26] CRYPTOCOCCAL PERITONITIS IN PATIENTS ON PERITONEAL-DIALYSIS
    SMITH, JW
    ARNOLD, WC
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1988, 11 (05) : 430 - 433
  • [27] Nontuberculous mycobacterial peritonitis in peritoneal dialysis patients
    Rho, Mira
    Bia, Frank
    Brewster, Ursula C.
    SEMINARS IN DIALYSIS, 2007, 20 (03) : 271 - 276
  • [28] Peritonitis influences mortality in peritoneal dialysis patients
    Fried, LF
    Bernardini, J
    Johnston, JR
    Piraino, B
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (10): : 2176 - 2182
  • [29] Shewanella algae Peritonitis in Patients on Peritoneal Dialysis
    Shanmuganathan, Malini
    Goh, Bak Leong
    Lim, Christopher
    NorFadhlina, Zakaria
    Fairol, Ibrahim
    PERITONEAL DIALYSIS INTERNATIONAL, 2016, 36 (05): : 574 - U243
  • [30] FUNGAL PERITONITIS IN PATIENTS ON PERITONEAL-DIALYSIS
    MICHEL, C
    COURDAVAULT, L
    ALKHAYAT, R
    VIRON, B
    ROUX, P
    MIGNON, F
    AMERICAN JOURNAL OF NEPHROLOGY, 1994, 14 (02) : 113 - 120